March 9, 2020 / 9:28 AM / a month ago

BRIEF-Zydus And Xoma Announce Il-2-Based Immuno-Oncology Therapy Licensing Agreement

March 9 (Reuters) - XOMA Corp:

* ZYDUS AND XOMA ANNOUNCE IL-2-BASED IMMUNO-ONCOLOGY THERAPY LICENSING AGREEMENT

* XOMA CORP - AS PART OF AGREEMENT, ZYDUS WILL ADVANCE NEW IO CANDIDATE THROUGH FORMAL CLINICAL TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below